PR84224

BALLINA (County Tipperary), Ireland, June 2, 2020 /PRNewswire=KYODO JBN/ --

Technopath Clinical Diagnostics today announced that it is rolling out COVID-19

antibody testing in Ireland to help businesses navigate a safer workplace

re-entry. This initiative will provide key services to all industries and will

be offered on a not-for-profit basis. As a global leader in the development of

quality control materials for the Diagnostics Industry, Technopath has been

hands-on since the beginning of the COVID-19 pandemic supporting many of the

larger global diagnostic companies as they develop antibody tests.

From recently launching the world's first third-party COVID-19 quality control

solutions allowing clinical laboratories to release patient test results with

confidence, Technopath is now offering its expertise, equipment and facilities

to provide antibody testing for businesses in Ireland using both the Abbott

Diagnostics and Roche Diagnostics testing platforms. The company believes

COVID-19 antibody testing could be part of the solution to reopening the

nation's economy.

"Companies in Ireland as well as around the world are looking for ways to

reopen their businesses by taking every step to reduce the risk of coronavirus

exposure while making employees feel safe returning to work," said Malcolm

Bell, CEO and founder of Technopath. "Given that the Department of Health is

now indicating that our nation may be facing a prolonged acute emergency for

the foreseeable future, there is an urgent need to equip companies with the

opportunity to offer their employees antibody tests. Underscored by our deep

experience in supporting diagnostic companies, these tests are assuming greater

importance in helping companies get back to work."

For the initial phase of the COVID-19 antibody testing initiative, Technopath

is partnering with Corporate Health Ireland, facilitating the immediate and

professional collection of blood samples ensuring secure and client

confidential reporting of results by one of the country's leading providers of

occupational health services.

Phase Two will explore partnering with other occupational health providers in

Ireland to make antibody tests available at workplaces helping to control the

spread of future COVID-19 infections. Furthermore, these tests will enable

people who have the antibodies in their blood an opportunity to donate their

plasma for therapeutic use and potentially help people with the most severe

cases of COVID-19 to recover more quickly.

For more about Technopath please visit:

https://www.technopathclinicaldiagnostics.com/about/our-company/

Logo - https://mma.prnewswire.com/media/1165846/Technopath_Logo.jpg

For Media:

Sunny Uberoi, Corporate Communications, + 1 917 747 2018, sunny@166media.com

For Corporate Health Ireland: Dr. Martin Hogan MB FRCPI FFOM, Director,

Corporate Health Ireland Ltd., +353 (0)21 435 0360, martin.hogan@CHI.ie

For Marketing & Communications: Len Lloyd, Director Marketing, Technopath

Clinical Diagnostics, + 353 61 525700, len.lloyd@technopathcd.com

Source:  Technopath Clinical Diagnostics